remain bullish follow upbeat mark solid volum
robust cash flow stabl commerci mix adjust ebitda-nci beat
addit de novo pipelin remain full sign clinic expect
open pace remain brisk reimburs backdrop look solid cash
flow remain strong view attract opportun
ramp time continu like busi fundament reiter buy
rais price target ebitda-nci
back network ramp opportun recent
unit resolut buy move back network
cut adjust ebitda-nci guidanc
assum uptick volum would expect ramp volum
move given compani in-network statu attract
footprint strong clinic qualiti addit contract includ valu
base featur aim improv qualiti lower hospit
dovetail nice qualiti metric leav compani well posit
capit
commerci mix stabl esa opportun commerci mix
touch yoy flat sequenti mix held steadi past
quarter non- product make product hover
around cost side continu view esa opportun
roughli half physician adopt micera end
compani see opportun potenti move
provid cost tailwind
pipelin remain strong sign clinic quarter end open activ
ramp de novo compani continu expect
open estim assum addit bolu open
late aid natx growth back half estim
assum acceler sequenti trend balanc year
reiter full year adjust ebitda-nci guidanc
assum personnel cost increas normal natx
slight benefit calcimimet rais adjust
tr target
ebitda consensu ebitda adjust non-
ebitda-nci estim
tie solid core trend on-going de novo open improv reimburs think
could build tailwind time reiter buy rate rais
price target
page
revenu
revenu
revenu
revenu
page
american renal lead provid dialysi servic focus exclus joint ventur
partnership model physician clinic state servic
patient partnership nephrologist
compani differenti busi model complement solid core industri trend little/no
discretionari spend strong free cash flow gener view stabl reimburs
environ addit model help fuel robust non-acquir treatment growth ara
meaning de novo develop activ complement station expans select
acquisit opportun provid attract tailwind given typic profit ramp facil
matur rate share buy
valuat risk
price target base trade ebitda-nci modest discount peer
hold fm buy view appropri given scale fm case diversifi
busi mix risk rate price target includ commerci mix labor cost pressur
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
